Global Digital Biomarkers Market 2023-2029

March 2023 | 64 pages | ID: GFB758C0EAA7EN
Gen Consulting Company

Abstracts

Digital biomarkers are a new category of biomarkers that use digital technologies to measure and track physiological and behavioral indicators of disease or health. Unlike traditional biomarkers, which are typically assessed through a blood sample or imaging test, digital biomarkers can be collected remotely and in real-time using wearable sensors, smartphones, or other digital devices. Examples of digital biomarkers include heart rate variability, sleep patterns, activity levels, and even vocal patterns. By analyzing these data points through machine learning and artificial intelligence algorithms, healthcare professionals can gain insights into an individual's health status and track changes over time. The global digital biomarkers market size is projected to grow by USD 23.2 billion from 2023 to 2029, registering a CAGR of 44.55 percent, according to the latest market data.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global digital biomarkers market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, system components, application, end user, and region. The global market for digital biomarkers can be segmented by type: clinical trials, clinical settings. Among these, the clinical settings segment was accounted for the highest revenue generator in 2022. Digital biomarkers market is further segmented by system components: wearables, mobile apps, implantables, data integration software. The wearables segment is estimated to account for the largest share of the global digital biomarkers market. Based on application, the digital biomarkers market is segmented into: gastrointestinal diseases, sleep and movement disorders, cardiovascular, psychiatric disorders (mood and behavior), chronic pain, neurodegenerative diseases, diabetes, respiratory diseases, others. The cardiovascular segment held the largest share of the global digital biomarkers market in 2022 and is anticipated to hold its share during the forecast period. On the basis of end user, the digital biomarkers market also can be divided into: biopharmaceutical companies, payers, providers. In 2022, the biopharmaceutical companies segment made up the largest share of revenue generated by the digital biomarkers market. Digital biomarkers market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By type: clinical trials, clinical settings
By system components: wearables, mobile apps, implantables, data integration software
By application: gastrointestinal diseases, sleep and movement disorders, cardiovascular, psychiatric disorders (mood and behavior), chronic pain, neurodegenerative diseases, diabetes, respiratory diseases, others
By end user: biopharmaceutical companies, payers, providers
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report has also analysed the competitive landscape of the global digital biomarkers market with some of the key players being Alphabet Inc., AliveCor Inc., Akili Interactive Labs, Inc., Dassault Syst?mes SE, IXICO plc, Koninklijke Philips N.V., Quanterix Corp., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global digital biomarkers market.
To classify and forecast the global digital biomarkers market based on type, system components, application, end user, region.
To identify drivers and challenges for the global digital biomarkers market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global digital biomarkers market.
To identify and analyze the profile of leading players operating in the global digital biomarkers market.

Why Choose This Report
Gain a reliable outlook of the global digital biomarkers market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY TYPE

Clinical trials
Clinical settings

PART 6. MARKET BREAKDOWN BY SYSTEM COMPONENTS

Wearables
Mobile apps
Implantables
Data integration software

PART 7. MARKET BREAKDOWN BY APPLICATION

Gastrointestinal diseases
Sleep and movement disorders
Cardiovascular
Psychiatric disorders (mood and behavior)
Chronic pain
Neurodegenerative diseases
Diabetes
Respiratory diseases
Others

PART 8. MARKET BREAKDOWN BY END USER

Biopharmaceutical companies
Payers
Providers

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

Alphabet Inc.
AliveCor Inc.
Akili Interactive Labs, Inc.
Dassault Syst?mes SE
IXICO plc
Koninklijke Philips N.V.
Quanterix Corp.

DISCLAIMER